The 2025 Parkinson Canada Research Grant Competition is returning this September. This research program supports promising trainees and researchers as … Read More
GBA1 Meeting 2024 Summary
Parkinson Canada had the pleasure of sponsoring and attending the first ever international meeting focused on GBA1. Held at the … Read More
Parkinson Canada attends the first-ever GBA1 meeting
Parkinson Canada is proudly sponsoring and attending the first ever GBA1 meeting, a conference for health professionals and stakeholders in … Read More
Key Takeaways From Our First Patient Engagement Workshop
Update on September 11th, 2024: We are pleased to inform you that a comprehensive report detailing the workshop’s findings is … Read More
Parkinson Canada announces over $ 1.9 million in research competition funding
Parkinson Canada would like to congratulate applicants who have been awarded funding in 2024 and acknowledge the hard work and … Read More
Unlocking early Parkinson’s detection: the power of blood-based biomarkers
Today, Parkinson’s Disease (PD) is still diagnosed by a visual examination of a patient’s physical symptoms (tremor, rigidity, bradykinesia). These … Read More
Redefining Parkinson’s through a new biological lens
Traditionally, a diagnosis of Parkinson’s Disease relies on a clinical assessment by a doctor based on established clinical criteria. The … Read More
Insights from the 2nd Annual Canadian Movement Disorders Meeting
3rd Annual Canadian Movement Disorders Meeting On Saturday, Nov. 25, we wrapped up the 2nd Annual Canadian Movement Disorders Meeting … Read More
Stem Cell-Based Therapies to Treat Parkinson’s
Parkinson’s disease (PD) is caused by decreased levels of dopamine, a chemical produced in the brain responsible for maintaining smooth … Read More
Transcranial Focused Ultrasound: “Opening” the door to the Blood Brain Barrier
A major hindrance to Parkinson’s disease (PD) treatment is the ability for drugs to “show up” where they are supposed … Read More